2019年2月15日 · Pulmonary arterial hypertension (PAH) is a clinical hemodynamic syndrome characterized by elevated pulmonary arterial pressure and pulmonary vascular resistance leading to right heart failure and death. Vascular remodeling is the most prominent histopathological feature of PAH, which is regulated by many factors.

Objectives: To compare the prevalence of unexplained pulmonary artery hypertension (PAH) in hemodialysis (HD) and peritoneal dialysis (PD) patients and to compare laboratory parameters between patients with unexplained PAH and those with normal pulmonary artery pressure (PAP).

Phá trinh là việc người đàn ông quan hệ và làm rách màng trinh của một cô gái. Nếu là người tâm lý, phái mạnh cần biết cách quan hệ nhẹ nhàng, tránh để nàng sợ hãi khi làm chuyện ấy lần đầu.

Welcome to the National Biological Sample and Data Repository for Pulmonary Arterial Hypertension (PAH). Also known as the "PAH Biobank", we are a National Institutes of Health/National Heart, Lung & Blood Institute funded resource of biological samples, genetic data, and clinical data for the PAH research community.

2018年11月21日 · Pulmonary arterial hypertension (PAH), a pulmonary vascular condition that includes the historic diagnosis of primary pulmonary hypertension (PPH), was once a progressive and fatal disorder for which there was no effective treatment. 1,2 However, in 2019, some forms of PAH are preventable (eg, anorexigen-associated PAH), and other forms of PAH ...

2024年5月1日 · Pulmonary hypertension encompasses a heterogeneous group of disorders with the common feature of elevated pulmonary artery pressures. Patients often present with worsening dyspnea on exertion, with signs of right heart strain or failure.

2024年10月31日 · Pulmonary hypertension (PH) is a haemodynamic condition characterised by elevation of mean pulmonary arterial pressure (mPAP) >20 mmHg, assessed by right heart catheterisation.

先天性心脏病相关 PAH 由多种病理生理学组成，包括 4 个亚组：Eisenmenger 综合征、与体肺分流相关的 PAH、伴有小/偶发心脏缺陷（如小房间隔缺损或室间隔缺损）的 PAH和心脏缺损闭合后的 PAH。

2022年12月5日 · Pulmonary arterial hypertension (PAH) in the setting of end-stage renal disease (ESRD) has important prognostic and therapeutic consequences.

2024年8月12日 · 目前治疗的局限性 PAH的复杂 血管病 理生物学特征，包括肺血管细胞过度增殖、细胞外基质沉积和血管周围炎性细胞浸润，对既定治疗提出了挑战。 目前PAH治疗的作用机制主要局限于通过纠正血管活性因子的失衡来实现血管扩张。